Oral microbiome-driven virulence factors: A novel approach to pancreatic cancer diagnosis
Biomolecules and Biomedicine · 2023
DOI: 10.17305/bb.2023.9934 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2023. Verfasst von Xuemin Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology Medical Center, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China; Central Laboratory of Affili…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Virulence Factors, Carcinoma, Pancreatic Ductal, Microbiota. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy, often associated with a poor prognosis for patients. One of the major challenges in managing PDAC is the difficulty in early diagnosis, owing to the limited and invasive nature of current diagnostic methods. Recent studies have identified the oral microbiome as a potential source of non-invasive biomarkers for diseases, including PDAC. In this study, we focused on leveraging the differential expression of virulence factors (VFs) encoded by the oral microbiome to create a diagnostic tool for PDAC. We observed a higher alpha diversity in VF categories among PDAC patients compared to healthy controls. We then identified a panel of VF categories that were significantly upregulated in PDAC patients, these being associated with bacterial adherence, exoenzyme production, and nutritional/metabolic processes. Moreover, Streptococcus-derived VFs were notably enriched in PDAC patients. We developed a diagnostic model using random forest analysis based on the levels of these VFs. The model's diagnostic accuracy was evaluated using receiver operating characteristic (ROC) curve analysis, with an area under the curve (AUC) of 0.88, indicating high accuracy in differentiating PDAC patients from healthy controls. Our findings suggest that VFs encoded by the oral microbiome hold potential as diagnostic tools for PDAC, offering a non-invasive approach that could significantly enhance early detection and prognosis, ultimately leading to improved patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Stomatology Medical Center, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China; Central Laboratory of Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Chin…
Zitieren
APA
Zeng, X., Ren, D., Liu, R., Zhang, Q., Yan, X., & Yuan, X. (2023). Oral microbiome-driven virulence factors: A novel approach to pancreatic cancer diagnosis. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2023.9934
Vancouver
Zeng X, Ren D, Liu R, Zhang Q, Yan X, Yuan X. Oral microbiome-driven virulence factors: A novel approach to pancreatic cancer diagnosis. Biomolecules and Biomedicine. 2023. doi:10.17305/bb.2023.9934
BibTeX
@article{Zeng2023,
author = {Zeng, Xuemin and Ren, Dapeng and Liu, Ran and Zhang, Qiang and Yan, Xiao and Yuan, Xiao},
title = {Oral microbiome-driven virulence factors: A novel approach to pancreatic cancer diagnosis},
journal = {Biomolecules and Biomedicine},
year = {2023},
doi = {10.17305/bb.2023.9934}
}
EUVIMED